Lung volumes and distensibility, and maximum respiratory pressures in thyroid disease before and after treatment S FREEDMAN From the Chace Wing, Enfield District Hospital, Enfield, Middx EN2 8JL, UK Freedman, S (1978) . Thorax, 33, [785] [786] [787] [788] [789] [790] Lung volumes and distensibility, and maximum respiratory pressures in thyroid disease before and after treatment. Lung volumes, static pressure volume curves of the lung, and maximum respiratory pressures were measured in six patients with thyrotoxicosis and three with myxoedema before and after treatment. After treatment three of the thyrotoxic patients had increases in vital capacity of the same order as previously reported, but in contrast to previous reports, the lung volume changes were not associated with, nor due to, concomitant changes in respiratory muscle performance. Static pulmonary compliance increased in four of the six patients. The initial findings were more in keeping with the presence of pulmonary congestion. Only one of the myxoedematous patients had any significant increase in vital capacity after treatment, and in her case this was clearly attributable to increased inspiratory muscle force.
A reduced vital capacity (VC) in patients with thyrotoxicosis was first noted in 1917 by Peabody and Wentworth who examined seven such patients and found that two of them had a VC less than 80% of predicted normal. This observation was confirmed by Rabinowitch (1923) and Lemon and Moersch (1924) . The reduction in VC is reversible with successful treatment and is associated with, and attributed to, weakness of the respiratory muscles with reduced maximum respiratory pressures (Stein et al, 1961; Wasserman 1962) . The only previous measurements of static pulmonary compliance were by Massey et al (1967) who found that in most cases it was normal although reduced in those patients with the biggest reductions in VC. Stein et al (1961) reported big reductions in dynamic compliance in contrast to Mcllroy et al (1956) who found it to be normal in two patients.
In myxoedema, uncomplicated by obesity or respiratory disease, VC has been found to be normal (Wilson and Bedell, 1960) .
The objects of the present study were to measure the elastic properties of the lungs and the performance of the respiratory muscles in thyrotoxicosis and myxoedema before and after treatment. A brief report has been published (Freedman, 1977) .
Methods
Six patients with thyrotoxicosis and three with myxoedema were studied. They all agreed to take part in the experiments after it had been explained that none (Milic-Emili et al, 1964) with the tip of the balloon being passed to a depth of 40-45 cm from the nares. The exact depth to which the balloon was passed at the first study was noted and was used again at the second visit. Balloon technique was otherwise as described by Milic-Emili et al, and pressures were measured using a HewlettPackard 267B transducer and displayed on the same manufacturers' four-channel recorder together with lung volume changes that were measured using a water spirometer. Static expiratory PV curves were measured by sequential interruption of airflow at the mouth during an expiration from total lung capacity (TLC). Each expiration was preceded by two vital capacity breaths. Sufficient measurements were taken to obtain at least three PV curves that agreed closely, and these were averaged by eye. In two cases (De and Lu) compliance was measured during a slow but uninterrupted expiration because the patients could not co-operate (quasi-static).
Maximum inspiratory and expiratory pressures were measured from the oesophageal balloon, using pleural-to-atmospheric pressure differences.
For these measurements, balloon volume was increased to 1 ml. Measurements were made at various lung volumes until the maximum pressures that could be sustained for at least two seconds were obtained with the patients either sucking or blowing against a closed tap. In practice the biggest pressures were found at volumes close to FRC, and it was found helpful to have a pinhole in the mouthpiece and to remove the noseclip during these manoeuvres. Normal values were taken from Cotes (1975 Pst ( L ) cm H20
Fig 1 Static expiratory pressure-volume curves in thyrotoxic patients before and after -----treatment. In patient De, two sets of measurements were made before treatment; a quasi-static measurement (no 1) when she was in cardiac failure and a static curve (no 2) when the failure had been resolved but before specific treatment. tln atrial fibrillation at time of presentation. For ali patients, data before and after treatment are given in each column, the first of each pair offigures being pretreatment.
All lung volumes reported as /. predicted normal values. Normal range for free thyroxine Index is 4 2-1S 0.
Figures in parenthesis for patient De refer to first study on admission when she was in congestive heart failure. The second study was done a week later after treatment with digitalis and diuretics.
with normal subjects reported by Brown et al (1954) and those of patients with atrial septal defect and pulmonary hypertension reported by De Troyer et al (1977) . Von Basch is credited by Gibson and Pride (1976) with first describing the effects of vascular engorgement on the PV curve -namely, a reduction in lung volumes and distensibility above FRC and a reduced recoil pressure with slightly increased volumes below FRC. I was unable to obtain many measurements below FRC but the size and direction of the changes in the PV curves is otherwise compatible with this explanation, which has the additional merit of fitting in with the known effects of thyrotoxicosis on the pulmonary circulation, which are to increase pulmonary blood flow with a proportional increase in pulmonary artery pressure (Bishop et al, 1955) . Although two of the three patients with appreciable increases in vital capacity were in cardiac failure at the time of presentation, changes in static compliance were not confined to these two patients and, moreover, the clinical signs of failure had resolved with treatment before the initial studies. Thus if pulmonary congestion was the explanation for the changes in the PV curve it can be present without overt signs of cardiac failure. Acute pulmonary vascular engorgement in normal subjects is also reported to produce a fall in dynamic compliance (Bondurant et al, 1957) .
Another possible explanation for the changes in compliance and in the PV curves is that they result from changes in tissue elastic properties or in pulmonary surface forces induced, in some way as yet undefined, by the thyrotoxicosis. There is no available evidence about this possibility, but nothing in the present or previous results excludes it.
The differences between the present findings and those of previous workers, especially Stein et al (1961) and Wassermann (1962) (Massumi and Winnacker, 1964 Burack et al (1971) who found no change in VC after treatment in five patients.
It thus appears that some non-obese patients with uncomplicated myxoedema may have a low VC that improves with treatment while others have normal lung volumes. The low VC is certainly attributable to respiratory muscle weakness in patient Lu and this would be a feasible mechanism for the reduction in VC previously reported, but the evidence is inconclusive. The position is certainly less clearly defined than has been stated (Bates et al, 1971) , both for myxoedema and thyrotoxicosis. The present results in thyrotoxicosis support the view of Lemon and Moersch (1924) : "As to the primary fundamental physicochemical cause of the decreased vital capacity in hyperthyroidism, we are still uncertain and must await further investigation. However, we believe the secondary and direct cause is the cardiac inefficiency which arises from the primary source, the thyroid." 
